Diagnostic Performance of Serum Biomarkers Fibroblast Growth Factor 21, Galectin-3 and Copeptin for Heart Failure with Preserved Ejection Fraction in a Sample of Patients with Type 2 Diabetes Mellitus

More than half of the patients with heart failure have preserved ejection fraction (HFpEF), however evidence shows a mortality rate comparable to those with reduced ejection fraction. The aim of this study was to evaluate whether FGF21, galectin-3 and copeptin can be used as biomarkers to identify H...

詳細記述

書誌詳細

出版年:	Diagnostics
主要な著者:	Raluca D. Ianoș, Călin Pop, Mihaela Iancu, Rodica Rahaian, Angela Cozma, Lucia M. Procopciuc
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2021-08-01
主題:	biomarkers heart failure preserved ejection fraction type 2 diabetes mellitus
オンライン･アクセス:	https://www.mdpi.com/2075-4418/11/9/1577